MOACM
CPRX

Mutual of America Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Mutual of America Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414K Sell
13,176
-46
-0.3% -$1.36K ﹤0.01% 1194
2026
Q1 		$327K Buy
13,222
+17
+0.1% +$405 ﹤0.01% 1179
2025
Q4 		$308K Buy
13,205
+318
+2% +$7.08K ﹤0.01% 1193
2025
Q3 		$254K Sell
12,887
-1,842
-13% -$37.9K ﹤0.01% 1236
2025
Q2 		$320K Sell
14,729
-1,598
-10% -$37.7K ﹤0.01% 1188
2025
Q1 		$396K Sell
16,327
-657
-4% -$14.8K ﹤0.01% 1163
2024
Q4 		$354K Buy
16,984
+204
+1% +$4.38K ﹤0.01% 1230
2024
Q3 		$334K Sell
16,780
-1,664
-9% -$30.8K ﹤0.01% 1262
2024
Q2 		$286K Sell
18,444
-797
-4% -$12.4K ﹤0.01% 1304
2024
Q1 		$307K Buy
19,241
+1,701
+10% +$25.6K ﹤0.01% 1296
2023
Q4 		$295K Sell
17,540
-20
-0.1% -$273 ﹤0.01% 1303
2023
Q3 		$205K Sell
17,560
-1,483
-8% -$19.8K ﹤0.01% 1373
2023
Q2 		$256K Sell
19,043
-674
-3% -$9.7K ﹤0.01% 1341
2023
Q1 		$327K Sell
19,717
-348
-2% -$5.74K ﹤0.01% 1245
2022
Q4 		$373K Buy
20,065
+1,246
+7% +$19.2K ﹤0.01% 1201
2022
Q3 		$241K Buy
+18,819
New +$223K ﹤0.01% 1302

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mutual of America Capital Management's CPRX Position: Q2 2026 in Review

Mutual of America Capital Management reduced its Catalyst Pharmaceutical (CPRX) stake by 0.35% in Q2 2026, selling an estimated $1.36K and leaving 13,176 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

Mutual of America Capital Management first reported a position in CPRX in Q3 2022 and has held it in 16 quarters since. 293 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Mutual of America Capital Management held 13,176 shares of Catalyst Pharmaceutical worth $414K as of Q2 2026.
  • Mutual of America Capital Management sold 46 Catalyst Pharmaceutical shares in Q2 2026, an estimated $1.36K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Mutual of America Capital Management's portfolio in Q2 2026, its #1194 holding.
  • Mutual of America Capital Management first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
  • 293 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.